Lin Zhuangbin, Li Xiaobo, Song Jianyuan, Zheng Rong, Chen Cheng, Li Anchuan, Xu Benhua
Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, China.
The Graduate School, Fujian Medical University, Fuzhou, China.
Front Oncol. 2022 Feb 15;12:816485. doi: 10.3389/fonc.2022.816485. eCollection 2022.
The purpose of this study was to investigate the relationship between lymph node harvest and the prognosis in locally advanced rectal cancer (LARC) patients after neoadjuvant chemoradiotherapy (nCRT).
Patients who were diagnosed with clinical LARC and treated with nCRT and radical surgery between June 2008 and July 2017 were included in this study. The relationship between lymph node retrieval and prognosis was analyzed. Other lymph node-related indicators were explored.
A total of 837 patients with a median follow-up of 61 (7-139) months were included in the study. The five-year DFS and OS rates of all patients were 74.9% and 82.3%, respectively. Multivariate survival analysis suggested that dissection of ≥ 12 lymph nodes did not improve OS or DFS. 7 was selected as the best cutoff value for the total number of lymph nodes retrieved by Cox multivariate analysis (χ2 = 10.072, HR: 0.503, P=0.002). Dissection of ≥ 5 positive lymph nodes (PLNs) was an independent prognostic factor for poorer DFS (HR: 2.104, P=0.004) and OS (HR: 3.471, p<0.001). A positive lymph node ratio (LNR) of more than 0.29 was also an independent prognostic factor for poorer DFS (HR: 1.951, P=0.002) and OS (HR: 2.434, p<0.001).
The recommends that at least 7 harvested lymph nodes may be more appropriate for LARC patients with nCRT. PLN and LNR may be prognostic factors for LARC patients with ypN+ after nCRT.
本研究旨在探讨新辅助放化疗(nCRT)后局部晚期直肠癌(LARC)患者的淋巴结清扫数量与预后之间的关系。
纳入2008年6月至2017年7月期间被诊断为临床LARC并接受nCRT和根治性手术治疗的患者。分析淋巴结清扫数量与预后之间的关系,并探索其他淋巴结相关指标。
本研究共纳入837例患者,中位随访时间为61(7 - 139)个月。所有患者的五年无病生存率(DFS)和总生存率(OS)分别为74.9%和82.3%。多因素生存分析表明,清扫≥12枚淋巴结并不能改善OS或DFS。通过Cox多因素分析,将7枚选为清扫淋巴结总数的最佳截断值(χ2 = 10.072,HR:0.503,P = 0.002)。清扫≥5枚阳性淋巴结(PLN)是DFS较差(HR:2.104,P = 0.004)和OS较差(HR:3.471,p < 0.001)的独立预后因素。阳性淋巴结比率(LNR)大于0.29也是DFS较差(HR:1.951,P = 0.002)和OS较差(HR:2.434,p < 0.001)的独立预后因素。
建议对于接受nCRT的LARC患者,至少清扫7枚淋巴结可能更为合适。PLN和LNR可能是nCRT后ypN +的LARC患者的预后因素。